查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1962103

全球醫療保健分銷市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Healthcare Distribution Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 123 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計醫療分銷市場規模將從 2025 年的 1.81 兆美元成長到 2034 年的 3.53 兆美元，2026 年至 2034 年的複合年成長率為 7.72%。

受醫療保健產業對高效可靠供應鏈解決方案需求的不斷成長的推動，醫療保健分銷市場預計將顯著成長。隨著全球醫療保健格局的演變，及時交付醫療用品、藥品和醫療設備變得至關重要。電子商務和數位平台的興起正在改變傳統的分銷模式，使醫療保健機構能夠簡化採購流程並加強庫存管理。溫控運輸和即時追蹤系統等物流創新進一步提高了醫療保健分銷的效率和可靠性，確保關鍵產品安全準時送達。

此外，以病人為中心的醫療服務日益受到重視，這也對醫療用品分銷市場產生了影響。隨著醫療機構致力於改善患者預後，對醫療用品和設備即時配送的需求不斷成長。這一趨勢在急診環境中尤其顯著，因為及時獲得必需品對患者照護至關重要。此外，遠端醫療和居家醫療服務的普及也增加了對支援偏遠地區患者照護的配送解決方案的需求，進一步擴大了市場潛力。

此外，監管合規和安全標準在醫療分銷市場中變得日益重要。由於醫療機構在醫療產品的處理和運輸方面面臨嚴格的監管，經銷商必須投資於品質保證和風險管理方法，以確保合規性。區塊鏈和人工智慧等先進技術的整合正在提高供應鏈的透明度和可追溯性，並加強對產品品質和安全的監控。總之，醫療分銷市場預計將迎來強勁成長，其特點是技術創新、以患者為中心的解決方案以及確保醫療產品安全高效交付的各項舉措。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球醫療分銷市場：按類型分類

  • 市場分析、洞察與預測
  • 藥品分銷服務 A（非處方藥、維生素、學名藥、品牌藥和原廠藥）
  • 生物製藥分銷服務 A（單株抗體、疫苗、重組蛋白、血液及血液製品及其他產品）
  • 醫療設備分銷服務

第5章：全球醫療分銷市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院藥房
  • 零售藥房
  • 其他

第6章：全球醫療保健分銷市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Alliance Healthcare
    • AmerisourceBergen Corporation
    • AndaInc
    • Cardinal HealthInc
    • Celesio AG
    • CuraScript SD
    • Henry ScheinInc
    • McKesson Corporation
    • Medline IndustriesInc
    • Morris & Dickson Co., LLC
    • Owens & MinorInc
    • Patterson CompaniesInc
    • Phoenix Group
    • Sinopharm Group
    • Suzuken Co.Ltd
簡介目錄
Product Code: VMR112115571

The Healthcare Distribution Market size is expected to reach USD 3.53 Trillion in 2034 from USD 1.81 Trillion (2025) growing at a CAGR of 7.72% during 2026-2034.

The healthcare distribution market is poised for significant growth, driven by the increasing demand for efficient and reliable supply chain solutions in the healthcare sector. As the global healthcare landscape evolves, the need for timely delivery of medical supplies, pharmaceuticals, and equipment has become paramount. The rise of e-commerce and digital platforms is transforming traditional distribution models, enabling healthcare providers to streamline their procurement processes and enhance inventory management. Innovations in logistics, such as temperature-controlled transportation and real-time tracking systems, are further improving the efficiency and reliability of healthcare distribution, ensuring that critical products reach their destinations safely and on time.

Moreover, the growing emphasis on patient-centered care is influencing the healthcare distribution market. As healthcare providers seek to improve patient outcomes, the demand for just-in-time delivery of medical supplies and equipment is increasing. This trend is particularly relevant in acute care settings, where timely access to essential products can significantly impact patient care. Additionally, the rise of telehealth and home healthcare services is driving the need for distribution solutions that cater to remote patient care, further expanding the market's potential.

Furthermore, regulatory compliance and safety standards are becoming increasingly important in the healthcare distribution market. As healthcare organizations face stringent regulations regarding the handling and transportation of medical products, distributors must invest in quality assurance and risk management practices to ensure compliance. The integration of advanced technologies, such as blockchain and artificial intelligence, is enhancing transparency and traceability in the supply chain, allowing for better monitoring of product quality and safety. In summary, the healthcare distribution market is set for robust growth, characterized by technological advancements, a focus on patient-centered solutions, and a commitment to ensuring the safe and efficient delivery of healthcare products.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • Pharmaceutical Product Distribution ServicesA (Otc Drugs/Vitamins, Generic Drugs, Brand-Name/Innovator Drugs)
  • Biopharmaceutical Product Distribution ServicesA (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Blood And Blood Products, Other Products)
  • Medical Device Distribution Services

By End-use

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

COMPANIES PROFILED

  • Alliance Healthcare, AmerisourceBergen Corporation, Anda, Inc, Cardinal Health, Inc, Celesio AG, CuraScript SD, Henry Schein, Inc, McKesson Corporation, Medline Industries, Inc, Morris Dickson Co, LLC, Owens Minor, Inc, Patterson Companies, Inc, Phoenix Group, Sinopharm Group, Suzuken Co, Ltd

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEALTHCARE DISTRIBUTION MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Pharmaceutical Product Distribution ServicesA (Otc Drugs/Vitamins, Generic Drugs, Brand-Name/Innovator Drugs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Biopharmaceutical Product Distribution ServicesA (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Blood And Blood Products, Other Products) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Medical Device Distribution Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEALTHCARE DISTRIBUTION MARKET: BY END-USE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End-use
  • 5.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEALTHCARE DISTRIBUTION MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Type
    • 6.2.2 By End-use
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Type
    • 6.3.2 By End-use
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Type
    • 6.4.2 By End-use
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Type
    • 6.5.2 By End-use
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Type
    • 6.6.2 By End-use
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL HEALTHCARE DISTRIBUTION INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Alliance Healthcare
    • 8.2.2 AmerisourceBergen Corporation
    • 8.2.3 AndaInc
    • 8.2.4 Cardinal HealthInc
    • 8.2.5 Celesio AG
    • 8.2.6 CuraScript SD
    • 8.2.7 Henry ScheinInc
    • 8.2.8 McKesson Corporation
    • 8.2.9 Medline IndustriesInc
    • 8.2.10 Morris & Dickson Co., LLC
    • 8.2.11 Owens & MinorInc
    • 8.2.12 Patterson CompaniesInc
    • 8.2.13 Phoenix Group
    • 8.2.14 Sinopharm Group
    • 8.2.15 Suzuken Co.Ltd